Alkermes Says in Deal to Sell Vivitrol in Russia

Jan 7 (Reuters) - Biotechnology company Alkermes Inc (ALKS.O: Quote, Profile, Research) said it entered into an agreement to sell Vivitrol, a drug that treats alcohol and opioid dependence, in Russia and some other countries.

MORE ON THIS TOPIC